[Anticardiolipin antibodies--detection and diagnostic value]

Area of Science:

• Immunology
• Rheumatology
• Pathogenesis of autoimmune diseases

Context:

• Anticardiolipin antibodies are associated with systemic lupus erythematosus (SLE), thromboembolic events, thrombocytopenia, and recurrent fetal loss.
• Previous studies indicate a significant prevalence of these antibodies in SLE patients.

Purpose:

• To determine the incidence of anticardiolipin antibodies in a cohort of SLE patients using a modified ELISA technique.
• To investigate potential correlations between anticardiolipin antibodies and disease activity or clinical manifestations like recurrent fetal loss.

Summary:

• A modified ELISA was used to test 53 SLE patient sera for anticardiolipin antibodies.
• Only two sera (4%) tested positive for anticardiolipin antibodies.
• One positive case was associated with recurrent fetal loss and active disease; no correlation with disease activity was found in general.

Impact:

• The study reveals a lower incidence of anticardiolipin antibodies in the tested SLE cohort compared to previous reports.
• Findings may refine understanding of anticardiolipin antibody relevance in specific SLE patient subgroups.
• Highlights the need for further research into regional or population-specific variations in antibody prevalence.